Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 2 weeks ago Source:  Transcatheter Academy
One-year outcomes from the LANDMARK trial show the Myval transcatheter heart valve (THV) series is noninferior to contemporary THVs for treating symptomatic severe native aortic stenosis.¹ The results demonstrate comparable clinical efficacy and haemodynamic performance at 1 year.MethodologyLANDMARK (NCT04275726) was a prospective, randomised, open-label, noninferiority trial conducted across 31… View more
Management of CAD in TAVI

Systematic Review

Author(s): Cian Murray , Caoimhe Ryan , Michael Cronin , et al Added: 8 months ago
Author(s): Marianna Adamo, Volker Rudolph, Marta Sitges ,et al Start date: Dec 03, 2025
Severe tricuspid regurgitation (TR) remains an under-recognised and under-treated condition, stressing the importance of timely identification and referral to improve clinical outcomes.In this interactive session, Prof Marianna Adamo (University of Brescia, Brescia, IT) and Prof Volker Rudolph (Heart and Diabetes Center NRW, Bad Oeynhausen, DE) moderate an expert faculty of Prof Marta Sitges … View more